Skip to content
Screener

Insmed INSM Other Non-Current Assets

Other Non-Current Assets at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$146.15M+75.8%
United Therapeutics logo
United TherapeuticsUTHR
$239.5M+2.7%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$138K-50.4%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$11.62M+41.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.31B
Savara logo
SavaraSVRA
$886K-11.5%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$21.46B+1.6%
Enterprise value$21.5B+5.3%
P/S18.9×-34.2×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:OtherAssets.

The source filing: Insmed’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041
Line itemAs of / June 30, 2026As of / December 31, 2025
Operating lease right-of-use assets13,17920,708
Intangibles, net93,48997,651
Goodwill136,110136,110
Other assets104,44497,378
Total assets$2,102,565$2,264,558
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities$428,929$456,060

Item 1C. Consolidated Financial Statements

FAQ

What is Insmed's other non-current assets?
Insmed (INSM) reported other non-current assets of $104.44M in Q2 2026.
How has Insmed's other non-current assets changed year-over-year?
Insmed's other non-current assets increased by 17.6% year-over-year, from $88.81M to $104.44M.
What is the long-term trend for Insmed's other non-current assets?
Over 5 years (2020 to 2025), Insmed's other non-current assets has grown at a 29.5% compound annual growth rate (CAGR), from $26.77M to $97.38M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Insmed's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude